Literature DB >> 19424069

The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all?

Dennis McGonagle1, Michael Benjamin, Ai Lyn Tan.   

Abstract

PURPOSE OF REVIEW: Both psoriasis and psoriatic arthritis (PsA), and by implication psoriatic nail disease, have been considered as autoimmune disorders. This was based on the assumption that T-cell-directed responses against common skin and synovial antigens led to shared immunopathological mechanisms at these different sites, which was indirectly supported by the human leucocyte antigen-Cw6 disease association. This study draws on recent microanatomical and genetic studies of PsA, psoriasis and psoriatic-associated nail disease to show how the prevailing autoimmunity concepts for psoriatic disease need to be redrawn, especially in the case of joint and nail disease. RECENT
FINDINGS: Recent microanatomical studies confirm that normal tendon and ligament insertion points to bone (entheses), the key territory for the inflammatory reaction associated with PsA, being subject to microdamage that strongly points to a role for microtrauma in the joints, which is reminiscent of Koebner responses in the skin. Furthermore, the nail is functionally integrated with entheses associated with the distal phalanx that provides anchorage to the skin and joint. Although type 1 psoriasis is strongly linked to the human leucocyte antigen-Cw6, recent genetic studies have suggested that both joint and nail disease do not share this association.
SUMMARY: These microanatomical and genetic insights have important implications for a better understanding of PsA and nail disease and for an improved understanding of the psoriatic disease spectrum.

Entities:  

Mesh:

Year:  2009        PMID: 19424069     DOI: 10.1097/BOR.0b013e32832c6ab9

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  24 in total

1.  [New aspects on the pathogenesis of psoriatic arthritis].

Authors:  A J Hueber; B Manger
Journal:  Z Rheumatol       Date:  2013-10       Impact factor: 1.372

2.  Trauma and psoriatic arthritis: is there a relationship?

Authors:  Regina M Taylor-Gjevre; Bindu Nair; John Gjevre; David Leswick
Journal:  Can Fam Physician       Date:  2012-11       Impact factor: 3.275

Review 3.  [Differential diagnostic spectrum of psoriasis vs. psoriatic arthritis in skin and joints].

Authors:  S Gerdes; U Mrowietz; U Wagner
Journal:  Z Rheumatol       Date:  2017-08       Impact factor: 1.372

4.  Which Psoriasis Patients Develop Psoriatic Arthritis?

Authors:  Kristine Busse; Wilson Liao
Journal:  Psoriasis Forum       Date:  2010

5.  Tailored approach to early psoriatic arthritis patients: clinical and ultrasonographic predictors for structural joint damage.

Authors:  Yasser El Miedany; Maha El Gaafary; Sally Youssef; Ihab Ahmed; Annie Nasr
Journal:  Clin Rheumatol       Date:  2014-05-03       Impact factor: 2.980

Review 6.  Psoriatic arthritis in South and Central America.

Authors:  Sergio M A Toloza; Rafael Valle-Oñate; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

7.  Comparative microscopic analysis of nail clippings from patients with cutaneous psoriasis and psoriatic arthritis.

Authors:  Gabriela Poglia Fonseca; Betina Werner; Gabriela Seidel; Henrique Luiz Staub
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

8.  Update of the management of chronic psoriasis: new approaches and emerging treatment options.

Authors:  Philip M Laws; Helen S Young
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-04-21

Review 9.  'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease.

Authors:  Dennis McGonagle; Sibel Zehra Aydin; Ahmet Gül; Alfred Mahr; Haner Direskeneli
Journal:  Nat Rev Rheumatol       Date:  2015-11-03       Impact factor: 20.543

Review 10.  Psoriatic arthritis: tissue-directed inflammation?

Authors:  Giacomo Cafaro; Iain B McInnes
Journal:  Clin Rheumatol       Date:  2018-02-23       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.